The use of the CyberKnife System allows a clinician to perform accurate treatment because of its capability to track the tumor throughout treatment.
Improving the outcomes that matter most — for your patients and your practice.
Read about the proven safety and efficacy of the CyberKnife® System for the treatment of trigeminal neuralgia.
Read about the safety and efficacy of CyberKnife SBRT for prostate cancer patients.
HEAD & NECK
Read about the superior clinical outcomes when treating head and neck cancer with helical TomoTherapy® over RapidArc.
The CyberKnife System provided a convenient and minimally invasive treatment option for patients with metastasis to para-aortic lymph nodes.
Treatment with CyberKnife radiosurgery utilizing a hypofractionated treatment regimen was indicated for maximum local control and to minimize injury to the optic apparatus.
Three months after treatment, the patient reported no evidence of local regional recurrence or treatment-related toxicity.
This patient had an excellent initial outcome with the CyberKnife System using Xsight® Lung Tracking; the patient was able to undergo treatment without implanted fiducials
Due to the risk of recurrence and intimate association of the lesion with the optic nerve, the CyberKnife® System was selected.
There were no further treatment possibilities as surgery, conventional radiation therapy and chemotherapy were already attempted without preventing tumor growth.
The treatment of both malignant as well as benign tumors of the spine using CyberKnife radiosurgery began in 1997. Treatment of spine lesions using single
Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.
The CyberKnife System provided a convenient and minimally invasive treatment option for this patient with recurrent ovarian carcinoma who had failed previous surgery and chemotherapy.